Literature DB >> 33217782

How to make better use of scientific knowledge for cancer prevention.

Pekka Puska1.   

Abstract

Cancer prevention research has produced profound scientific knowledge that has led to the development of several evidence-based prevention strategies. But do these research outcomes lead to preventive action in real life? Many factors contribute to the so-called 'implementation gap' between prevention recommendations and their application and adherence, including individual actions and behaviour, health service structures and political actions. This article discusses factors underlying the implementation gap in both clinical- and population-based prevention. Understanding how these factors contribute to the implementation gap is important for planning successful cancer prevention strategies, as well as generally achieving disease prevention.
© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; evidence; implementation gap; prevention

Mesh:

Year:  2020        PMID: 33217782      PMCID: PMC7931119          DOI: 10.1002/1878-0261.12858

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  5 in total

1.  IANPHI-10 years of collaboration for institutional public health.

Authors:  Puska Pekka; Koplan P Jeffrey
Journal:  Eur J Public Health       Date:  2017-04-01       Impact factor: 3.367

2.  Health in all policies--from what to how.

Authors:  Pekka Puska
Journal:  Eur J Public Health       Date:  2014-02       Impact factor: 3.367

3.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

4.  European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk.

Authors:  Joachim Schüz; Carolina Espina; Patricia Villain; Rolando Herrero; Maria E Leon; Silvia Minozzi; Isabelle Romieu; Nereo Segnan; Jane Wardle; Martin Wiseman; Filippo Belardelli; Douglas Bettcher; Franco Cavalli; Gauden Galea; Gilbert Lenoir; Jose M Martin-Moreno; Florian Alexandru Nicula; Jørgen H Olsen; Julietta Patnick; Maja Primic-Zakelj; Pekka Puska; Flora E van Leeuwen; Otmar Wiestler; Witold Zatonski
Journal:  Cancer Epidemiol       Date:  2015-07-09       Impact factor: 2.984

Review 5.  Cancer Prevention Europe.

Authors:  Christopher P Wild; Carolina Espina; Linda Bauld; Bernardo Bonanni; Hermann Brenner; Karen Brown; Joakim Dillner; David Forman; Ellen Kampman; Mef Nilbert; Karen Steindorf; Hans Storm; Paolo Vineis; Michael Baumann; Joachim Schüz
Journal:  Mol Oncol       Date:  2019-02-13       Impact factor: 6.603

  5 in total
  2 in total

1.  Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.

Authors:  Rutu Hemani; Ishani Patel; Ninad Inamdar; Gisella Campanelli; Virginia Donovan; Avinash Kumar; Anait S Levenson
Journal:  Cancer Prev Res (Phila)       Date:  2021-10-21

Review 2.  Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer.

Authors:  Babak Arjmand; Shayesteh Kokabi Hamidpour; Akram Tayanloo-Beik; Parisa Goodarzi; Hamid Reza Aghayan; Hossein Adibi; Bagher Larijani
Journal:  Front Genet       Date:  2022-01-27       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.